Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma

Neuroblastoma (NB) is the most common extracranial solid tumor in childhood with 5-year survival rate of 40% in high-risk patients despite intensive therapies. Recently, adoptive cell therapy, particularly chimeric antigen receptor (CAR) T cell therapy, represents a revolutionary treatment for hemat...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanichapol, Thitinee, Chutipongtanate, Somchai, Anurathapan, Usanarat, Hongeng, Suradej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845499/
https://www.ncbi.nlm.nih.gov/pubmed/29682521
http://dx.doi.org/10.1155/2018/1812535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845499/
https://www.ncbi.nlm.nih.gov/pubmed/29682521
http://dx.doi.org/10.1155/2018/1812535

Ejemplares similares